AI PLATFORM FOR THERAPEUTIC DEVELOPMENT
Build Therapies
Faster.
Atlas connects scientific evidence, clinical intelligence, patents, funding and study preparation around one therapeutic program.
- Evidence-linked
- Every insight connects to its sources.
- Program-scoped
- Intelligence stays anchored to your program.
- Persistent memory
- Decisions and evidence compound over time.
Therapeutic programs don’t fail because teams lack information.
They fail because it’s fragmented.
Scientific literature
Thousands of papers
Clinical trials
Across multiple registries
Patents & IP
Complex landscapes
Internal knowledge
Scattered and siloed
Funding & grants
Hard to discover
Study plans
Time-consuming to build
Atlas connects them around your program.
Atlas in action
See how Atlas connects evidence to decisions.
From scientific literature to clinical trials, patents, funding and study design — explore how Atlas brings it all together around your program.
Watch the videoFrom discovery to development.
1. Discover
Map the science, mechanisms, targets and emerging evidence.
2. Assess
Evaluate clinical, competitive and IP landscapes.
3. Decide
Identify gaps, contradictions and the next best bets.
4. Advance
Secure funding, design studies and prepare submissions.
Every insight is connected to evidence.
Traceable sources, confidence levels and contradictions highlighted.
See how it worksTGF-β pathway inhibition shows conflicting results on fibrosis progression.
| Study | Finding | Confidence | Source |
|---|---|---|---|
| PMID: 37156915 | Inhibition reduced fibrosis in preclinical models | High | JCI Insight, 2023 |
| PMID: 40983070 | No significant benefit in similar models | Medium | Front. Pharmacol., 2025 |
| NCT04512345 | Phase 1 trial terminated early | High | ClinicalTrials.gov |
Illustrative example — not a live Atlas query result.
View full context in Atlas
Move your program forward with evidence you can trace.
Atlas is the intelligence layer for teams building the next generation of therapeutics.